Ethical Considerations Relative to In Utero Somatic Cell and Gene Therapies (discussion and presentation from the minutes of the December 1-2, 1994 meeting of the RAC)
National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee
Human Gene Therapy 1995 August; 6(8): 1065, 1077-1078, 1095- 1096
Showing items related by title, author, creator and subject.
Recombinant DNA Advisory Committee: Minutes of Meeting, 1-2 Dec 1994 -- Parts VII and XV: Ethical Considerations Relative To Unknown author (United States. National Institutes of Health. Recombinant DNA Advisory Committee, 1995-08)
Recombinant DNA Advisory Committee Human Gene Therapy Subcommittee. Minutes of Meeting, December 9 1988 National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee. (1989-03)
The Conduct of Clinical Trials of Maternal-Infant Transmission of HIV Supported by the United States Department of Health in Developing Countries: A Summary of the Needs of Developing Countries, the Scientific Applications, and the Ethical Considerations Assessed by the National Institutes of Health and the Centers for Disease Control and Prevention 1994-1997 Includes as an Appendix: Recommendations From the Meeting on Mother-to-Infant Transmission of HIV by Use of Antiretrovirals, Geneva 23-25 June 1994 Unknown author (United States. Department of Health and Human Services, 1997-07)